AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates

(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Monday that it intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates or ADCs with a view to supporting global supply of its ADC portfolio. https://www.nasdaq.com/articles/astrazeneca-to-build-$1.5-bln-manufacturing-facility-in-singapore-for-antibody-drug